Tert-Butylamine

Tert-Butylamine

SCHEMBL7372525

CC(C)(C)N.CC(C)(C)NC(=O)c1ccc(N)cc1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEIDH1

The experimentally established mechanism targets of Tert-Butylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
MEN1 O00255 1/20 0.50
POLB P06746 1/20 0.50
PKM P14618 1/20 0.50
APEX1 P27695 1/20 0.50
KMT2A Q03164 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
EPHX2 P34913 1/20 0.49
JAK2 O60674 1/20 0.48
HTT P42858 1/20 0.47
ESRRG P62508 1/20 0.46
MAPT P10636 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HIF1A Q16665 1/20 0.46
SLC22A6 Q4U2R8 1/20 0.46
SLC22A8 Q8TCC7 1/20 0.46
PTGS1 P23219 2/20 0.45
AOC3 Q16853 2/20 0.44
MAOB P27338 1/20 0.44
SIRT2 Q8IXJ6 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL854187 0.96 LMNA (0.53) LMNAMEN1POLBPKMAPEX1
SCHEMBL13270520 0.91 JAK2 (0.57) LMNAMEN1POLBPKMAPEX1
SCHEMBL15946360 0.86 LMNA (0.73) LMNAMEN1POLBPKMAPEX1
SCHEMBL17865779 0.85 LMNA (0.58) LMNAPOLBJAK2HTTMAPT
SCHEMBL21016381 0.80 EPHX2 (0.51) LMNAEPHX2JAK2HTTESRRG
SCHEMBL6417124 0.80 LMNA (0.50) LMNAMEN1KMT2AHTTAOC3
SCHEMBL19625786 0.80 LMNA (0.50) LMNAMEN1KMT2AHTTAOC3
SCHEMBL11936034 0.80 EPHX2 (0.56) LMNAMEN1POLBPKMAPEX1
SCHEMBL2522600 0.79 LMNA (0.53) LMNAPOLBKMT2AJAK2HTT
SCHEMBL22987120 0.79 MAPT (0.49) LMNAMEN1POLBPKMAPEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0912171-A1 BENZAMIDE TREATMENT OF DEMENTIA ASSOCIATED WITH AIDS VIRUS (HIV-1) INFECTION CENTAUR PHARMACEUTICALS, INC. (US) 1999-05-06 EP disclosed
WO-1997038684-A1 BENZAMIDE TREATMENT OF DEMENTIA ASSOCIATED WITH AIDS VIRUS (HIV-1) INFECTION CENTAUR PHARMACEUTICALS, INC. (US) 1997-10-23 WO disclosed